Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks has a partnership with Selecta Biosciences, Inc. to develop ImmTOR technology platform. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.

Ginkgo Bioworks Holdings, Inc.

Grow by Ginkgo

At Ginkgo, we use biology to grow the future. Companies across industries leverage our platform to design, develop, and optimize products for a breadth of commercial applications. We help our partners grow key ingredients for vaccines, crops that rely less on fossil fuel-based fertilizers, plant-based meat that tastes like the real thing, materials for the next generation of circular fashion, and so much more. We know our unique experiences, ideas, and perspectives are essential to our success and enable us to make biology easier to engineer and ensure equitable distribution of the benefits of our platform. As such, we seek to ensure that DEI is in our DNA, continuing to grow an inclusive culture and diverse workforce. Let's make biology easier to engineer and join our team.

Synlogic

Empede Capital

General Atlantic

Y Combinator

Bill Gates

Cascade Investment

T. Rowe Price

Viking Global Investors

Illumina

Ginkgo Bioworks, Inc.

Today on Foundry Theory we're all about iGEM - the heart of synthetic biology.
https://hubs.la/Q02kdx3q0

Humans of Ginkgo Bioworks is an interview series, featuring Sudeep Agarwala, that dives into the exciting technology at Ginkgo.

Today, we've released the final part of our three-part interview with Ginkgo’s head of ALE, Simon Trancart!

In Part 3, Simon discusses how our partners are working with us to make automated ALE at Ginkgo accessible to new industries.

Read it here:
https://hubs.la/Q02k9M_00

Catch up on Part 1 here: https://hubs.la/Q02k9Pbj0

And Part 2 here: https://hubs.la/Q02k9M8z0

Thank you, Elaine Watson and AgFunder, for the great featuring of our offering and strategic collaborations with Ginkgo Bioworks, Inc. and dsm-firmenich toward launching our products.

Tal Zeltzer | Sandro Tomita | Fredrik Hjelmqvist | David Borhani | Kevin Madden

#DOD Biomanufacturing RFP is out 👇🏻👇🏻 

https://lnkd.in/e6Bk8jtW

When I started my NSC detail, I knew very little about #biomanufacturing but after drinking from a firehose on the topic for a few months I came to see the plethora of ways this growing ecosystem of bio companies and technologies can strengthen America; from improving sustainability, strengthening supply chains, and growing the economy.

This RFP is an opportunity to invest in building Biomanufacturing capacity across the country. It's great to see it posted.

Congrats to all the people who worked hard to get this done: Kate Sixt Peter Emanuel Michelle Rozo Kirsten Kulcsar Weand, PhD Anne Cheever Georgia Lagoudas Sarah Glaven Douglas Friedman Robert Fisher Ben Buchanan Ishan K. Sharma and many others.

Check out Nita Madhav and friends as they figure out how to ensure we don't have another major biological event in our lifetimes. https://lnkd.in/eN94t7_F

Die Teilnehmer*innen der Delegationsreise in die USA hatte die Gelegenheit, Ginkgo Bioworks, Inc. zu besuchen und einen Einblick in deren Entwicklung und Labors zu erhalten.

Ginkgo Bioworks ist ein Biotech-Unternehmen, das sich auf die gentechnische Herstellung von Bakterien für industrielle Anwendungen spezialisiert hat. Die Expertise des Unternehmens erstreckt sich über die Entwicklungen von Mikroorganismen bis hin zur Herstellung von synthetischen Zellen, die schließlich die Grundlage für die Produktion verschiedener Materialien bilden können.

Der Besuch ermöglichte es neueste Fortschritte und Innovationen im Bereich der Genomtechnologie zu erkunden. Die Labors boten Einblicke in die Präzisionsarbeit, die hinter der Entwicklung maßgeschneiderter Mikroorganismen steht. Philipp Heuermann zeigten die internationalen Perspektiven von Ginkgo Bioworks auf.

VDMA, Wittenstein Stiftung, Universität Hohenheim, Universität Stuttgart, Baden-Württemberg International (BW_i), Thomas Bauernhansl

This is biology's century.

Just as computer science transformed the 20th century, biological science will transform the 21st. 

Alison Snyder explores growing global competition to harness that science to develop and make biotechnology products at scale.

More in In Axios Science👇🏾 

https://lnkd.in/eakijuky

“Biology is the only substrate, the only scientific discipline, that is capable of solving the great challenges of the world—food security, climate change, human health—all of those are biological problems”🦠🧬🧫🌱🍄🐝

Enjoyed chatting with Mark Sullivan at Forbes about the intersection of AI and Biology. 

https://lnkd.in/eZH8EZQ6

Thanks to the The Burn Bag and Andrea Ochoa for a great conversation about biology as a domain of operations, bio-intelligence (BIOINT), and the coming era of biosecurity.

Listen here: bit.ly/49muHGI

Ginkgo Bioworks, Inc.

Are your new product development efforts limited by commercially available enzyme technology? What if you could discover or design the exact enzyme needed to unlock your next innovation? See how one of our customers utilized Ginkgo's scale, automation, and AI algorithms to discover their unique enzyme. 

Interested? Contact us here to learn more! https://hubs.la/Q02jV4hY0

Filer	Shares	Latest Filing Date	Previously owned	Change	Share-Type	Market Value
Baillie Gifford & Co	241.08M	2023-07-28	242.87M	-1.79M	Shares	448.41M
Anchorage Capital Group, L....	69.85M	2023-08-14	69.85M	0	Shares	129.93M
General Atlantic, L.P.	32.32M	2023-08-11	32.32M	0	Shares	60.12M
Sb Investment Advisers (Uk)...	24.43M	2023-08-14	24.43M	0	Shares	45.44M
Trybe Capital Management Lp	3.78M	2023-08-14	1.05M	2.73M	Shares	7.03M
Equitec Proprietary Markets...	3.20M	2023-07-12	3.65M	-445.06K	Shares	5.95M
No Street Gp Lp	3M	2022-11-14	0	3M	Shares	9.36M
Plustick Management Llc	2.36M	2022-11-14	2.10M	257.47K	Shares	7.36M
Allen Operations Llc	2.25M	2022-11-07	2.25M	0	Shares	7.02M
Three Bridge Wealth Advisor...	833.80K	2023-07-28	833.80K	0	Shares	1.55M
Brevan Howard Capital Manag...	698.55K	2023-08-14	698.55K	0	Shares	1.30M
Boston Standard Wealth Mana...	606.63K	2023-07-06	606.63K	0	Shares	1.13M
Chescapmanager Llc	438.27K	2023-08-14	438.27K	0	Shares	815.18K
Chescapmanager Llc	388.27K	2022-11-14	388.51K	-243	Shares	1.21M
Areion Asset Management Co Ltd	379.64K	2021-10-20	0	379.64K	Shares	4.40M
Areion Asset Management Co Ltd	379.64K	2021-10-19	0	379.64K	Shares	4.40M
Tao Capital Management Lp	227.35K	2023-08-14	227.35K	0	Shares	423K
Aj Wealth Strategies, Llc	197.20K	2023-07-20	197.20K	0	Shares	366.79K
Capital Impact Advisors, Llc	182.09K	2023-08-14	182.09K	0	Shares	338.68K
Raymond James Financial Ser...	73.55K	2023-07-25	72.17K	1.38K	Shares	136.80K
Guild Investment Management...	69.65K	2023-07-20	70.20K	-550	Shares	129.55K
Rothschild Investment Corp /Il	61.90K	2023-07-18	61.90K	0	Shares	115K
Resolute Advisors Llc	36.72K	2023-08-09	36.72K	0	Shares	68.29K
Claraphi Advisory Network, Llc	34.88K	2023-02-15	10.84K	24.04K	Shares	58.95K
Ae Wealth Management Llc	23.77K	2023-07-10	21.21K	2.55K	Shares	44.20K
Iridian Asset Management Ll...	21.91K	2023-08-09	24.06K	-2.15K	Shares	40.74K
Guidance Point Advisors, Llc	20K	2023-11-06	15K	5K	Shares	37.20K
Cowen Prime Advisors Llc	15K	2022-08-01	0	15K	Shares	36K
Chicago Capital, Llc	10.35K	2023-07-20	0	10.35K	Shares	19.25K
Koss-Olinger Consulting, Llc	10K	2023-07-31	10K	0	Shares	19K
Financial Consulate, Inc	10K	2022-10-20	10K	0	Shares	31K
Columbia Advisory Partners Llc	10K	2023-08-02	0	10K	Shares	18.60K
Ashburton (Jersey) Ltd	5K	2023-07-19	0	5K	Shares	9K
Worth Asset Management, Llc	600	2023-07-11	300	300	Shares	1.12K
Bartlett & Co. Llc	500	2023-07-14	500	0	Shares	1K
Cambridge Trust Co	200	2023-07-25	0	200	Shares	372
Symmetry Peak Management Llc	0	2023-08-14	85K	-85K	Shares	0
Point72 Middle East Fze	0	2023-08-14	163.26K	-163.26K	Shares	0
Privium Fund Management B.V.	0	2023-07-26	177.50K	-177.50K	Shares	0

NYSE:DNA

Ginkgo Bioworks Holdings, Inc.

Last Close

0.86

03/05 20:00

Market Cap

2.73B

Beta: 0.89

Volume Today

54.56M

Avg: 18.92M

PE Ratio

−2.78

PFCF: −6.38

Institutional trades

Institutional Ownership

Current holdings institutionals